Related content

Pemetrexed versus vinorelbine treatment of advanced nonsquamous non-small cell lung cancer in elderly patients

By Chen  

Molecular and Clinical Oncology, Vol. 1, Iss. 3, 2013-01 ,pp. : 553-557

Spandidos Publications

Access to resources Recommend Favorite

Misjudgement of gefitinib efficacy in patients with central non-smallcell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy

By                

Molecular and Clinical Oncology, Vol. 2, Iss. 4, 2014-01 ,pp. : 535-538

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of peripheral and local forkhead box p3+ regulatory T cells in patients with non-smallcell lung cancer

By                    

Molecular and Clinical Oncology, Vol. 2, Iss. 5, 2014-01 ,pp. : 685-694

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of chemotherapy plus gefitinib treatment in advanced nonsmallcell lung cancer patients following acquired resistance to gefitinib

By    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 875-878

Spandidos Publications

Access to resources Recommend Favorite

Histological subtype and smoking status, but not gender, are associated with epidermal growth factor receptor mutations in non-smallcell lung cancer

By                      

Molecular and Clinical Oncology, Vol. 2, Iss. 2, 2014-01 ,pp. : 252-258

Spandidos Publications

Access to resources Recommend Favorite